Mar 3, 2026 03:44PM
Mar 3, 2026 12:00PM
Mar 2, 2026 06:47AM
Feb 26, 2026 08:30AM
Feb 25, 2026 04:45PM
Feb 24, 2026 09:08AM
Feb 4, 2026 08:30AM SAREPTA gets approval to test Huntington's disease treatment in humans
Jan 27, 2026 06:43AM
Jan 26, 2026 12:54PM
Jan 26, 2026 08:01AM
Jan 26, 2026 05:30AM
Jan 26, 2026 05:18AM
Jan 23, 2026 04:05PM
Jan 14, 2026 06:55AM H.C. Wainwright Reiterates Sell Rating on Sarepta Therapeutics (SRPT)
Jan 14, 2026 04:39AM
Jan 12, 2026 11:59AM
Jan 12, 2026 09:30AM
Jan 8, 2026 03:59AM
Jan 7, 2026 08:31AM
Dec 11, 2025 11:53AM
Dec 9, 2025 06:50AM Wedbush Starts Sarepta Therapeutics (SRPT) at Outperform
Nov 25, 2025 08:58AM
Nov 25, 2025 07:31AM
Nov 24, 2025 07:31AM
Nov 24, 2025 07:30AM
Nov 20, 2025 03:59AM
Nov 14, 2025 02:59PM
Nov 14, 2025 02:02PM FDA approves new safety warning and revised indication that limits use for Elevidys following reports of fatal liver injuryHHS: FDA approves new safety warning and revised indication that limits
Nov 5, 2025 10:07AM
Nov 5, 2025 04:33AM
Nov 4, 2025 05:13AM
Nov 3, 2025 04:41PM
Nov 3, 2025 04:17PM
Nov 3, 2025 04:13PM
Oct 8, 2025 12:07PM Jefferies Reiterates Buy Rating on Sarepta Therapeutics (SRPT), 'Several Dynamics to Follow But Optics Could Further Improve in 2026'
Oct 7, 2025 06:37AM
Sep 22, 2025 07:18AM
Sep 22, 2025 05:04AM
Sep 16, 2025 05:19AM
Aug 27, 2025 08:39AM
Aug 25, 2025 06:41AM
Aug 24, 2025 07:06PM Mizuho on Sarepta Therapeutics (SRPT): 'Lowering 3Q25 Elevidys Sales Below Consensus'
Aug 21, 2025 10:16AM
Aug 20, 2025 04:23PM
Aug 13, 2025 04:13PM
Aug 12, 2025 01:25PM
Aug 11, 2025 01:59PM
Aug 11, 2025 01:22PM
Aug 11, 2025 10:42AM Freedom Broker Upgrades Sarepta Therapeutics (SRPT) to Buy
Aug 8, 2025 12:22PM

341,965 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All